Press Releases
Acasti Pharma Reports Third Quarter Results Print
Tuesday, January 17 2012

Acasti Pharma Reports Third Quarter Results

 
Acasti Pharma to Present at OneMedForum Conference Print
Monday, January 09 2012

Acasti Pharma to Present at OneMedForum Conference

 
Acasti to Present at The American Academy of Anti-Aging Medicine (A4M) and to The American Academy of Private Physicians Print
Wednesday, December 07 2011

Acasti Pharma to Present at The American Academy of Anti-Aging Medicine (A4M) and to
The American Academy of Private Physicians

 
Acasti Pharma Announces the Initiation of a Second Phase II Clinical Study and Consolidation of its IP Position Print
Monday, December 05 2011

Acasti Pharma Announces the Initiation of a Second Phase II Clinical Study and Consolidation of its IP Position

 
Acasti Receives Health Canada Clearance for an Open-Label Phase II Hypertriglyceridemia Trial Print
Monday, October 17 2011

Acasti Pharma Inc. Receives Health Canada Clearance for an Open-Label Phase II Hypertriglyceridemia Trial

 
Acasti Pharma Reports Second Quarter Results Print
Friday, October 14 2011

Acasti Pharma Reports Second Quarter Results

 
Acasti Pharma Announces the Initiation of Phase II Clinical Study of CaPre® for the treatment of Hypertriglyceridemia Print
Tuesday, October 04 2011

Acasti Pharma Announces the Initiation of Phase II Clinical Study of CaPre® for the treatment of Hypertriglyceridemia

 
Acasti to Present at JMP Healthcare Conference Print
Wednesday, September 21 2011

 Acasti Pharma to Present at JMP Healthcare Conference

 
Acasti Reports on Its Oversubscribed Rights Offering Print
Friday, September 16 2011

Acasti Pharma Reports on Its Oversubscribed Rights Offering

 
Clarification on Acasti Pharma Rights Offering Print
Thursday, September 08 2011

 Clarification on Acasti Pharma Rights Offering

 
<< Start < Prev 1 2 3 4 5 Next > End >>

Webcast at OneMedforum

 

Safe and effective
pharmaceutical and
medical applications...